| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9004608 | Biomedicine & Pharmacotherapy | 2005 | 4 Pages |
Abstract
The initial results show that different neoadjuvant anti-aromatase therapies has similar efficacy but the combination with celecoxib may have an advantageous effects on the serum lipid profiles.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
L.W.C. Chow, C.W.L. Cheng, J.L.N. Wong, M. Toi,